v3.23.1
Common Stock and Share-Based Compensation - Restricted Stock Awards (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Jan. 28, 2023
USD ($)
$ / shares
shares
Jan. 29, 2022
USD ($)
$ / shares
shares
Jan. 30, 2021
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based payment arrangement, expense, tax benefit | $ $ 0.0 $ 0.0 $ 1.0
Class A Common Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted (in shares) | shares 6,200,000 5,200,000 18,400,000
Restricted stock units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exchange ratio 1    
Grants in period, weighted average grant date fair value (in dollars per share) | $ / shares $ 31.43    
Granted (in shares) | shares 5,536,250    
Nonvested award, cost not yet recognized, amount | $ $ 161.4    
Nonvested award, cost not yet recognized, period for recognition 2 years 10 months 24 days    
Restricted stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grants in period, weighted average grant date fair value (in dollars per share) | $ / shares $ 0 $ 29.42 $ 1.16
Granted (in shares) | shares 0 742,972 8,272,704
Nonvested award, cost not yet recognized, amount | $ $ 4.1    
Nonvested award, cost not yet recognized, period for recognition 1 year 9 months 18 days    
Equity instruments other than options, vested in period, fair value | $ $ 12.7 $ 16.8 $ 5.1
Restricted stock | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Restricted stock | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grants in period, weighted average grant date fair value (in dollars per share) | $ / shares $ 0   $ 1.15
Granted (in shares) | shares 0 0 2,006,448